Proliferative effects on gastric ECL cells are present in almost all MEN1/ZES patients because chronic hypergastrinemia exists at some point in all patients with MEN1/ZES, and it is lifelong in 90–100%. The gene discussed is MEN1; the disease is Zollinger-Ellison syndrome.